作者：Ocuphire Pharma(RNN)
| 发布于: | 公告 | 转发：0 | 回复：0 | 喜欢：0 |
$Rexahn制药(RNN)$ 8-K - Current report Filed: 2019-01-22 AccNo: 0001140361-19-001362 Size: 44 KBItem 2.02: Results of Operations and Financial ConditionItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接